Literature DB >> 17025377

Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil): profile report.

M Asif A Siddiqui1, Caroline M Perry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025377     DOI: 10.2165/00063030-200620050-00006

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


× No keyword cloud information.
  3 in total

1.  Cancer immunotherapy: Making allies of phagocytes.

Authors:  Steven Fiering
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

2.  Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020.

Authors:  Yu Hu; Xuejiao Pan; Linzhi Shen; Fuxing Chen; Ying Wang; Hui Liang; Yaping Chen; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA.

Authors:  Ashley Ojeaga; Ernest Alema-Mensah; Desiree Rivers; Ijeoma Azonobi; Brian Rivers
Journal:  J Cancer Educ       Date:  2019-02       Impact factor: 1.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.